Checked processes every Belgian company, act by act, from the Belgian Official Gazette. The data below is real and verified, this company's full, act-by-act verified dossier is still being assembled.
Summary
Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of ReGenesys is 1.3% (low). The 2021 annual accounts show negative equity (€-5.04M) and a net result of €-2.96M. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 5% of 102 sector peers (fiscal year 2021). The company has been active since 2005 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 4 annual accounts.
Bankruptcy probability (12 mo)
Checked model v1 · free for everyoneStatistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Signals
Insufficient current data: the most recent filed accounts (financial year 2021) are too old to derive current signals.
Trust signals
2 signalsAdministrative Flags
Financials
Annual accounts & ratios
Source: NBB · 2021How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | -790.4% | 58.4% | |
| Net result | €-2.96M | €11k | |
| Equity | €-5.04M | €99k | |
| Staff costs | €1.25M | €230k | |
| Total assets | €637k | €218k |
| Fiscal year | 2021 |
|---|---|
| Revenue | €1.00M |
| EBITDA | €-2.61M |
| Net profit | €-2.96M |
| Cash flow | €-2.75M |
| Staff costs | €1.25M |
| Income taxes | €-44k |
| Dividends | - |
| Total assets | €637k |
| Equity | €-5.04M |
| Debt | €5.67M |
| of which ≤ 1y | €5.62M |
| of which > 1y | - |
| Working capital | €-5.25M |
| Employees (FTE) | 13.2 |
| 2021 | |
|---|---|
| Current ratio | 0.07 |
| Quick ratio | 0.07 |
| Working capital ratio | -823.3% |
| Solvency | -790.4% |
| Debt / equity | -1.13 |
| Long-term debt ratio | - |
| Interest coverage | -21.63 |
| Gross margin | - |
| Net margin | -295.3% |
| ROA | -465.0% |
| ROE | 58.8% |
| EBITDA margin | -260.6% |
| Days sales outstanding | 4d |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2021 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €637k |
| Fixed assets | 21/28 | €261k |
| Tangible fixed assets | 22/27 | €239k |
| Financial fixed assets | 28 | €21k |
| Current assets | 29/58 | €377k |
| Stocks & contracts in progress | 3 | €0 |
| Amounts receivable within one year | 40/41 | €181k |
| Cash & bank | 54/58 | €116k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €637k |
| Equity | 10/15 | €-5.04M |
| Contributions / capital | 10/11 | €1.00M |
| Accumulated profits (losses) | 14 | €-6.04M |
| Amounts payable | 17/49 | €5.67M |
| Amounts payable within one year | 42/48 | €5.62M |
| Trade debts payable within one year | 44 | €371k |
| Income statement | ||
| Turnover | 70 | €1.00M |
| Operating result | 9901 | €-2.83M |
| Financial income | 75 | €50 |
| Financial charges | 65 | €121k |
| Result before taxes | 9903 | €-3.01M |
| Income taxes | 67/77 | €-44k |
| Net result for the period | 9904 | €-2.96M |
| Result to be appropriated | 9905 | €-2.96M |
Health barometer
FY 2021 · computedUnlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →Structure & network
Locations & real estate
Registered office
on the map · from the address registerEstablishment units
1 locationReal-estate footprint
Source: CBE × cadastre · address linkingParcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24040B0201/00H002 | Flanders | 7,000 m² | 1 · 1,139 m² | 17.0 m · 4 fl. |
Publications
Lifecycle & Insolvency Signals
Belgisch Staatsblad · acts
15 acts30-06-2022 1 director appointed, 3 resigning
- Dan Camardo, Bestuurder, klasse a
- William Otto Lehmann Jr., Klasse a bestuurder
- Ivor Macleod, Klasse a bestuurder
- Nina Verbaenen, Persoon belast met het dagelijks bestuur
10-05-2022 Bart Laurens Theo Vaes resigns as persoon belast met dagelijks beheer
25-03-2021 1 director appointed, 1 resigning
- Ivor Macleod, A bestuurder
- Dr. Gil Bradford Van Bokkelen, A bestuurder
04-03-2020 2 directors appointed
- Ernst & Young Bedrijfsrevisoren, Commissaris
- Eric Van Hoof, Vertegenwoordiger van de commissaris
09-01-2020 Articles of association amended
21-11-2019 2 directors appointed
- Bart Laurens Theo Vaes, Dagelijks bestuur
- Nina Gisella Paul Verbaenen, Dagelijks bestuur
31-01-2018 Publication in the Belgian Official Gazette, Miscellaneous
17-01-2018 Articles of association amended
16-12-2016 Nina Verbaenen appointed as volmacht
12-12-2016 CellAR Comm. V. resigns as manager
25-11-2016 Ernst & Young Bedrijfsrevisoren Burg. CVBA appointed as statutory auditor
29-03-2016 Capital decrease of €2,328,025 to €500,000
29-01-2016 Publication in the Belgian Official Gazette, Miscellaneous
27-01-2016 Capital increase of €1,360,000 to €1,828,025
16-10-2015 2 directors appointed, 1 resigning
- Wesley Clemens, Volmacht
- Kris Verhees, Volmacht
- Dr. Robert Deans, Volmacht
Analysis
Snowflake analysis
financial profile on 5 axesFragile profile, watch health in particular.
All 5 axes are computed from data Checked has read.
Ask AI about this company
Checked AISoon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.
AI due-diligence brief
Checked AIGenerate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
Credit advice
verdict per customer and amountSimilar
Similar companies
Same sector, ranked by comparable sizeCompany registry
Company registry (CBE)
Crossroads Bank| Legal nameNL | ReGenesys |